-+ 0.00%
-+ 0.00%
-+ 0.00%

*Immunovant: FDA Discussions Planned for Later This Yr to Determine the Path Forward Regarding the Registrational Program for IMVT-1402 in D2T RA >IMVT

Dow Jones·11/09/2026 12:16:00

Please log in to view news